Editas Medicine, Inc. (EDIT): auditor change — Editas Medicine dismisses EY, appoints PwC as independent auditor for FY2026

Editas Medicine, Inc.

Audit Committee dismissed EY effective April 1, 2026; EY notified on April 2, 2026.
PwC appointed as new independent registered public accounting firm for FY ending Dec 31, 2026.
No disagreements or reportable events with EY during FY2024, FY2025, or interim period.
EY's letter to SEC filed as Exhibit 16.1, agreeing with the disclosure.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Editas Medicine, Inc. dismissed Ernst & Young LLP as its auditor.

Action: dismissal
Auditor: Ernst & Young LLP
Successor: PricewaterhouseCoopers LLP

Exact text from the filing

dismissed Ernst & Young LLP (“Ernst & Young”) as the Company’s independent registered public accounting firm, effective immediately

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Editas Medicine, Inc. engaged PricewaterhouseCoopers LLP as its auditor.

Action: engagement
Auditor: PricewaterhouseCoopers LLP

Exact text from the filing

appointed PricewaterhouseCoopers LLP (“PwC”) to serve as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2026

View on SEC.gov

Browse all auditor changes →

Editas Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001650664-26-000030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.